GC Cell Corporation (KOSDAQ:144510)
13,600
+100 (0.74%)
Sep 1, 2026, 3:30 PM KST
GC Cell Revenue
GC Cell had revenue of 41.60B KRW in the quarter ending June 30, 2026, a decrease of -3.14%. This brings the company's revenue in the last twelve months to 162.00B, down -4.97% year-over-year. In the year 2025, GC Cell had annual revenue of 165.52B, down -5.12%.
Revenue (ttm)
162.00B
Revenue Growth
-4.97%
P/S Ratio
1.25
Revenue / Employee
241.43M
Employees
671
Market Cap
202.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 165.52B | -8.93B | -5.12% |
| Dec 31, 2024 | 174.45B | -13.09B | -6.98% |
| Dec 31, 2023 | 187.54B | -48.58B | -20.57% |
| Dec 31, 2022 | 236.12B | 67.81B | 40.29% |
| Dec 31, 2021 | 168.31B | 82.75B | 96.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bioneer | 338.01B |
| MEDIPOST | 74.84B |
| HLB Therapeutics | 64.45B |
| GC Genome | 32.64B |
| SillaJen | 10.92B |
| Anterogen.Co.,Ltd. | 8.37B |
| Genexine | 5.81B |
| Genomictree | 3.83B |